These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20547818)

  • 1. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.
    Vesga O; Agudelo M; Salazar BE; Rodriguez CA; Zuluaga AF
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3271-9. PubMed ID: 20547818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea.
    Kim HK; Choi SM; Kang G; Park KH; Lee DG; Park WB; Rhee SJ; Lee S; Jung SI; Jang HC
    Yonsei Med J; 2020 Apr; 61(4):301-309. PubMed ID: 32233172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.
    Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    BMC Infect Dis; 2010 Jun; 10():153. PubMed ID: 20525378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: true bioequivalence of a generic product of intravenous metronidazole.
    Agudelo M; Vesga O
    Antimicrob Agents Chemother; 2012 May; 56(5):2659-65. PubMed ID: 22330928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model.
    Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    Antimicrob Agents Chemother; 2012 Jan; 56(1):243-7. PubMed ID: 22064531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
    Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O
    PLoS One; 2019; 14(2):e0211096. PubMed ID: 30726248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.
    Zuluaga AF; Agudelo M; Cardeño JJ; Rodriguez CA; Vesga O
    PLoS One; 2010 May; 5(5):e10744. PubMed ID: 20505762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.
    Zuluaga AF; Agudelo M; Rodriguez CA; Vesga O
    BMC Clin Pharmacol; 2009 Jan; 9():1. PubMed ID: 19149891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
    Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O
    Int J Antimicrob Agents; 2015 Feb; 45(2):161-7. PubMed ID: 25481459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits.
    Tattevin P; Saleh-Mghir A; Davido B; Ghout I; Massias L; Garcia de la Maria C; Miró JM; Perronne C; Laurent F; Crémieux AC
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1157-62. PubMed ID: 23254435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam.
    Rodriguez CA; Agudelo M; Aguilar YA; Zuluaga AF; Vesga O
    PLoS One; 2016; 11(5):e0155806. PubMed ID: 27191163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States.
    Louie A; Boyne MT; Patel V; Huntley C; Liu W; Fikes S; Kurhanewicz S; Rodriquez J; Robbins N; Brown D; Baluya D; Drusano GL
    Antimicrob Agents Chemother; 2015 Jan; 59(1):622-32. PubMed ID: 25385113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.
    Agudelo M; Rodriguez CA; Pelaez CA; Vesga O
    Antimicrob Agents Chemother; 2014; 58(2):1005-18. PubMed ID: 24277034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
    Zuluaga AF; Rodriguez CA; Agudelo M; Vesga O
    BMC Res Notes; 2015 Oct; 8():546. PubMed ID: 26445936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
    Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    Int J Antimicrob Agents; 2017 Feb; 49(2):189-197. PubMed ID: 27988068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus.
    Lepak AJ; Zhao M; Andes DR
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
    Gonzalez JM; Rodriguez CA; Zuluaga AF; Agudelo M; Vesga O
    PLoS One; 2015; 10(11):e0141872. PubMed ID: 26536105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin.
    Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O
    Antimicrob Agents Chemother; 2015 Jan; 59(1):53-8. PubMed ID: 25313208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inferiority of generic product compared with branded vancomycin: a paradigm shift.
    Jong GW
    Ther Drug Monit; 2012 Feb; 34(1):2-3. PubMed ID: 22210101
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
    Wang J; Shan Q; Ding H; Liang C; Zeng Z
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3008-12. PubMed ID: 24614373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.